OrsoBio
Gans Ganapati is a seasoned professional with extensive experience in leadership and strategic roles within the life sciences and healthcare sectors. Currently serving as Managing Partner at NuevaBio since January 2022, Gans also co-founded and holds the positions of Board Member and Chief Business Officer at both OrsoBio and MitoPower. Previous significant roles include Board Member at Strand Life Sciences and HealthCare Global Enterprises Ltd., where Gans was a co-founder, as well as VP of Corporate Development at Adamas Pharmaceuticals, Inc. and CEO at Triesta Sciences. Early career experience includes Vice President in Mergers and Acquisitions at Credit Suisse First Boston and a TAS Officer at Tata Industries Limited. Gans Ganapati holds an MBA from The Wharton School, a PGDM from the Indian Institute of Management Ahmedabad, and a B. Tech. in Mechanical Engineering from the Indian Institute of Technology, Madras.
This person is not in any teams
OrsoBio
OrsoBio, Inc. is a privately held, clinical-stage biopharmaceutical company dedicated to developing therapies to treat severe metabolic disorders, including type 2 diabetes, severe dyslipidemias, lipodystrophies, and nonalcoholic steatohepatitis. OrsoBio currently has four programs in clinical and preclinical development with first-in-class compounds that address central pathways in energy metabolism.